Cargando…
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
BACKGROUND: Gout is the most common type of inflammatory arthritis. Nonsteroidal anti-inflammatory drugs, corticosteroids, and colchicine are the first-line agents, although they are contraindicated in many patients. Blockade of IL-1 with anakinra can be an alternative. OBJECTIVE: To present a case...
Autores principales: | Jeria-Navarro, Sicylle, Gomez-Gomez, Alejandro, Park, Hye Sang, Calvo-Aranda, Enrique, Corominas, Hector, Pou, Maria Antonia, Diaz-Torne, Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877612/ https://www.ncbi.nlm.nih.gov/pubmed/36714095 http://dx.doi.org/10.3389/fmed.2022.1089993 |
Ejemplares similares
-
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
por: Ottaviani, Sébastien, et al.
Publicado: (2013) -
Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020) -
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)
por: Hernández-Cruz, Blanca, et al.
Publicado: (2022) -
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study)
por: Hernández-Cruz, Blanca, et al.
Publicado: (2022) -
Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis
por: Díaz-Torné, Cèsar, et al.
Publicado: (2019)